Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development & Regulatory Highlights: FDA Approval Announced of APADAZ™ (benzhydrocodone and...
-
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for March 29th, 2018, 4:30 p.m. ET CORALVILLE, Iowa, March 21, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a...
-
Results Suggest that Data from Single Classroom-style Efficacy Study May Be Applicable Across Pediatric, Adolescent and Adult ADHD Patient Populations CORALVILLE, Iowa, March 20, 2018 (GLOBE...
-
Presentations to Highlight Corporate and Clinical Progress CORALVILLE, Iowa, March 06, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the...
-
Apadaz is the First Prodrug of Hydrocodone/Acetaminophen to be Approved by FDA Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 2:30 p.m. ET CORALVILLE, Iowa,...
-
Corporate Updates and Clinical Progress to be Highlighted CORALVILLE, Iowa, Feb. 13, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company...
-
CORALVILLE, Iowa, Jan. 31, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq:KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs,...
-
Additional Patent Granted for the KP511-related family, a Prodrug of Hydromorphone CORALVILLE, Iowa, Jan. 23, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty...
-
‘Classroom-style’ Pivotal Efficacy Trial of ADHD Prodrug Composition Candidate to Study Onset and Duration of Efficacy and Product Safety Screening commenced in November; first patient treatment...
-
All Clinical and Non-Clinical Programs Remain on Track for ADHD Prodrug Candidate, Pivotal Efficacy Trial to Study Duration of Therapy to Initiate Prior to Year-End CORALVILLE, Iowa, Nov. 16, 2017 ...